This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
£33.97
Share price
0.00%
Change (1 day)
114.44%
Change (1 year)
Categories
Earnings for Albireo Pharma (ALBO)
Earnings in 2022 (TTM): -£0.11 Billion
According to Albireo Pharma's latest financial reports the company's current earnings are £57.39 Million. In 2021 the company made an earning of -£26.19 Million, an increase over its 2020 earnings that were of -£82.83 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Albireo Pharma from 2007 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2022 (TTM)  | -£0.11 Billion | 320.06% |
| 2021 | -£26.19 Million | -68.38% |
| 2020 | -£82.83 Million | 71.62% |
| 2019 | -£48.27 Million | 36.07% |
| 2018 | -£35.47 Million | 90.44% |
| 2017 | -£18.63 Million | |
| 2015 | -£13.26 Million | 5.37% |
| 2014 | -£12.59 Million | -9.62% |
| 2013 | -£13.93 Million | -9.08% |
| 2012 | -£15.32 Million | 104.33% |
| 2011 | -£7.5 Million | -70.07% |
| 2010 | -£25.04 Million | -26.1% |
| 2009 | -£33.88 Million | 3.76% |
| 2008 | -£32.65 Million | 42.47% |
| 2007 | -£22.92 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -£0.11 Billion | 5.90% | 🇺🇸 USA |